Psychedelic treatments could revolutionize the way millions are treated for mental health issues., So far, according to Vice, “The use of psychedelic drugs as an underground self-treatment for mental health conditions is on the rise, according to the world’s largest drug survey, with thousands of people turning to substances like LSD, MDMA, psilocybin and ketamine to treat psychiatric illnesses and emotional distress.”
“Of the 110,000 worldwide respondents to the 2020 Global Drug Survey, 6,500 (just under six percent) reported using recreational drugs as a DIY mental health treatment,” they added.
Helping, according to The Deep Dive, “Canaccord Genuity released a primer into five psychedelic companies that they “believe could mature into leaders within their respective fields, some as soon as this year,” adding that some companies have “raised over $800 million, and between them 100 – 150 clinical trials which use psychedelic compounds are commencing.”